VALQ - ETF AI Analysis
Top Page
American Century STOXX U.S. Quality Value ETF (VALQ)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, including major health care and technology companies, have shown strong gains this year, helping support the ETF’s overall performance.
Broad Sector Diversification
The fund spreads its investments across many sectors such as technology, health care, consumer stocks, and industrials, which helps reduce the impact if any one area of the market struggles.
Moderate Expense Ratio
The ETF’s expense ratio is reasonably low for an actively managed, factor-focused strategy, allowing investors to keep more of their returns compared with many higher-cost funds.
Negative Factors
Heavy Tilt Toward Technology
With a large share of assets in technology stocks, the fund could be more sensitive to swings in that sector than a more evenly balanced ETF.
Single-Country Concentration
Almost all of the ETF’s holdings are in U.S. companies, so investors do not get much diversification from international markets.
Mixed Performance Among Top Holdings
While many top positions have done well, at least one major holding has shown weak performance this year, which can drag on the fund’s overall results.
VALQ vs. SPDR S&P 500 ETF (SPY)
AUM361.35M
RegionNorth America
Expense Ratio0.29%
Beta0.70
IssuerAmerican Century
Inception DateJan 11, 2018
Dividend Yield1.73%
Asset ClassEquity
Index TrackedAmerican Century U.S. Quality Value Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,492
30 Day Avg. Volume5,650
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
81.48Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering223
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VALQ Summary
VALQ is the American Century STOXX U.S. Quality Value ETF, which follows the American Century U.S. Quality Value Index. It invests in U.S. companies that appear financially strong but reasonably priced, aiming to give investors broad exposure to the overall U.S. stock market with a value tilt. The fund holds well-known names like Apple and Procter & Gamble, along with many other stocks across technology, health care, and consumer sectors. Someone might invest in VALQ for long-term growth and diversification using a value-focused approach. A key risk is that it can rise or fall with the stock market and is meaningfully exposed to tech-related companies.
How much will it cost me?The American Century STOXX U.S. Quality Value ETF (VALQ) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it uses a specialized strategy to focus on high-quality, undervalued U.S. companies. The added cost reflects the fund's emphasis on disciplined stock selection and value investing.
What would affect this ETF?The VALQ ETF, with its focus on high-quality U.S. value stocks, could benefit from economic stability and growth in sectors like technology and healthcare, which make up a significant portion of its holdings. However, rising interest rates or economic downturns might negatively impact consumer-focused and cyclical sectors, while regulatory changes could affect top holdings like IBM and Cisco. Broad exposure to the U.S. market provides diversification but also ties performance closely to domestic economic conditions.
VALQ Top 10 Holdings
VALQ’s story is all about steady U.S. value names doing the heavy lifting, with a tilt toward tech and health care. Merck and Bristol-Myers are rising and quietly powering returns, while Cisco has been a standout gainer despite some recent wobbling. Union Pacific is also chugging along nicely, adding industrial strength to the mix. On the flip side, Procter & Gamble looks a bit tired and Lowe’s has been lagging, acting as mild brakes on performance. Overall, the fund is U.S.-only, diversified but not shy about its tech and health-care bias.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Merck & Company | 2.87% | $9.79M | $368.94B | 76.36% | 80 Outperform | |
| Bristol-Myers Squibb | 2.77% | $9.45M | $136.76B | 41.90% | 78 Outperform | |
| Lockheed Martin | 2.50% | $8.54M | $130.60B | 23.75% | 70 Outperform | |
| Verizon | 2.21% | $7.54M | $205.37B | 13.27% | 81 Outperform | |
| Procter & Gamble | 2.14% | $7.29M | $332.72B | -8.85% | 69 Neutral | |
| Cisco Systems | 2.04% | $6.97M | $442.03B | 62.32% | 77 Outperform | |
| Union Pacific | 1.94% | $6.63M | $182.78B | 37.50% | 72 Outperform | |
| Salesforce | 1.83% | $6.26M | $206.43B | -0.10% | 80 Outperform | |
| Charles Schwab | 1.80% | $6.13M | $186.85B | 12.74% | 74 Outperform | |
| International Business Machines | 1.73% | $5.89M | $224.97B | -3.24% | 79 Outperform |
VALQ Technical Analysis
Positive
―
Price Trends
70.44
Positive
68.74
Positive
67.46
Positive
Market Momentum
0.69
Positive
61.40
Neutral
52.99
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VALQ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 72.18, equal to the 50-day MA of 70.44, and equal to the 200-day MA of 67.46, indicating a bullish trend. The MACD of 0.69 indicates Positive momentum. The RSI at 61.40 is Neutral, neither overbought nor oversold. The STOCH value of 52.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VALQ.
VALQ Peer Comparison
Comparison Results
Performance Comparison
VALQ
American Century STOXX U.S. Quality Value ETF
72.56
10.03
16.04%
VFVA
Vanguard U.S. Value Factor ETF
―
―
―
VLU
SPDR S&P 1500 Value Tilt ETF
―
―
―
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
AIVL
WisdomTree U.S. AI Enhanced Value Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents